Arshad M, Azad A, Chan P, Vigneswara V, Feldinger K, Nafi S, et al. Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models. Br J Cancer. 2024;130:1990-2002 pubmed publisher

Fang R, Haxaire C, Otero M, Lessard S, Weskamp G, McIlwain D, et al. Role of iRhoms 1 and 2 in Endochondral Ossification. Int J Mol Sci. 2020;21: pubmed publisher

Wang S, Li R, Ng T, Luthria G, Oudin M, Prytyskach M, et al. Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy. Sci Adv. 2020;6:eaaz8521 pubmed publisher

Sampera A, Sánchez Martín F, Arpi O, Visa L, Iglesias M, Menendez S, et al. HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer. Mol Cancer Ther. 2019;18:2135-2145 pubmed publisher

Li J, Bai T, Gao S, Zhou Z, Peng X, Zhang L, et al. Human rhomboid family-1 modulates clathrin coated vesicle-dependent pro-transforming growth factor α membrane trafficking to promote breast cancer progression. EBioMedicine. 2018;36:229-240 pubmed publisher

Arcidiacono P, Webb C, Brooke M, Zhou H, Delaney P, Ng K, et al. p63 is a key regulator of iRHOM2 signalling in the keratinocyte stress response. Nat Commun. 2018;9:1021 pubmed publisher

Wilson J, Kefaloyianni E, Stopfer L, Harrison C, Sabbisetti V, Fraenkel E, et al. Functional Genomics Approach Identifies Novel Signaling Regulators of TGFα Ectodomain Shedding. Mol Cancer Res. 2018;16:147-161 pubmed publisher

Miura Y, Sukawa Y, Hironaka S, Mori M, Nishikawa K, Tokunaga S, et al. Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G). Gastric Cancer. 2018;21:84-95 pubmed publisher

Haghgoo S, Khosravi A, Mortaz E, Pourabdollah Toutkaboni M, Seifi S, Sabour S, et al. Prognostic value of rare and complex mutations in EGFR and serum levels of soluble EGFR and its ligands in non-small cell lung carcinoma patients. Clin Biochem. 2017;50:293-300 pubmed publisher

Kefaloyianni E, Muthu M, Kaeppler J, Sun X, Sabbisetti V, Chalaris A, et al. ADAM17 substrate release in proximal tubule drives kidney fibrosis. JCI Insight. 2016;1: pubmed publisher

Zhang C, Spevak W, Zhang Y, Burton E, Ma Y, Habets G, et al. RAF inhibitors that evade paradoxical MAPK pathway activation. Nature. 2015;526:583-6 pubmed publisher

Dombernowsky S, Samsøe Petersen J, Petersen C, Instrell R, Hedegaard A, Thomas L, et al. The sorting protein PACS-2 promotes ErbB signalling by regulating recycling of the metalloproteinase ADAM17. Nat Commun. 2015;6:7518 pubmed publisher

Dreymueller D, Martin C, Schumacher J, Groth E, Boehm J, Reiss L, et al. Smooth muscle cells relay acute pulmonary inflammation via distinct ADAM17/ErbB axes. J Immunol. 2014;192:722-31 pubmed publisher

Breshears L, Schlievert P, Peterson M. A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1). J Biol Chem. 2012;287:32578-87 pubmed

Richards F, Tape C, Jodrell D, Murphy G. Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model in vivo. PLoS ONE. 2012;7:e40597 pubmed publisher

Inoue A, Arima N, Ishiguro J, Prestwich G, Arai H, Aoki J. LPA-producing enzyme PA-PLA?? regulates hair follicle development by modulating EGFR signalling. EMBO J. 2011;30:4248-60 pubmed publisher

Yasumoto K, Yamada T, Kawashima A, Wang W, Li Q, Donev I, et al. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer. Clin Cancer Res. 2011;17:3619-30 pubmed publisher

Murthy A, Defamie V, Smookler D, Di Grappa M, Horiuchi K, Federici M, et al. Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice. J Clin Invest. 2010;120:2731-44 pubmed publisher

Hickinson D, Marshall G, Beran G, Varella Garcia M, Mills E, South M, et al. Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib. Clin Transl Sci. 2009;2:183-92 pubmed publisher

Inoue Y, Miyamoto S, Fukami T, Shirota K, Yotsumoto F, Kawarabayashi T. Amphiregulin is much more abundantly expressed than transforming growth factor-alpha and epidermal growth factor in human follicular fluid obtained from patients undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2009;91:1035-41 pubmed publisher

Yotsumoto F, Yagi H, Suzuki S, Oki E, Tsujioka H, Hachisuga T, et al. Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Biochem Biophys Res Commun. 2008;365:555-61 pubmed

Rumelhard M, Ramgolam K, Hamel R, Marano F, Baeza Squiban A. Expression and role of EGFR ligands induced in airway cells by PM2.5 and its components. Eur Respir J. 2007;30:1064-73 pubmed

Zhou B, Peyton M, He B, Liu C, Girard L, Caudler E, et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell. 2006;10:39-50 pubmed

Sakai K, Yokote H, Murakami Murofushi K, Tamura T, Saijo N, Nishio K. In-frame deletion in the EGF receptor alters kinase inhibition by gefitinib. Biochem J. 2006;397:537-43 pubmed

Baginski T, Dabbagh K, Satjawatcharaphong C, Swinney D. Cigarette smoke synergistically enhances respiratory mucin induction by proinflammatory stimuli. Am J Respir Cell Mol Biol. 2006;35:165-74 pubmed

Miyamoto S, Hirata M, Yamazaki A, Kageyama T, Hasuwa H, Mizushima H, et al. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res. 2004;64:5720-7 pubmed